Julian Topaly

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Epstein Barr Virus

Diffuse Large B Cell Lymphoma

Top Venues

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Boris Kubuschok, Burkhard Otremba, Manfred Welslau, Julian Topaly, Thomas Wolff, Georg Lenz, Michael Grau, Larissa Bittencourt da Silva, Ines Brückmann, Tobias Foierl
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP. Annals of hematology 103 (8) (2024)
Boris Kubuschok, Burkhard Otremba, Manfred Welslau, Julian Topaly, Thomas Wolff, Georg Lenz, Michael Grau, Larissa Bittencourt da Silva, Ines Brückmann, Tobias Foierl
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP. Annals of hematology 103 (8) (2024)
Boris Kubuschok, Burkhard Otremba, Manfred Welslau, Julian Topaly, Thomas Wolff, Georg Lenz, Michael Grau, Larissa Bittencourt da Silva, Ines Brückmann, Tobias Foierl
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP. Annals of hematology 103 (8) (2024)
Boris Kubuschok, Burkhard Otremba, Manfred Welslau, Julian Topaly, Thomas Wolff, Georg Lenz, Michael Grau, Larissa Bittencourt da Silva, Ines Brückmann, Tobias Foierl
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP. Annals of hematology (2024)
Boris Kubuschok, Burkhard Otremba, Manfred Welslau, Julian Topaly, Thomas Wolff, Georg Lenz, Michael Grau, Larissa Bittencourt da Silva, Ines Brückmann, Tobias Foierl
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP. Annals of hematology 103 (8) (2024)